Skip to main content
. 2023 Jun 28;26(7):107215. doi: 10.1016/j.isci.2023.107215

Figure 2.

Figure 2

Effects of Ca-EDTA, aztreonam and ceftazidime/avibactam and their combination in vitro

(A) biofilm biovolume and (B) biofilm cell viability (%) of carbapenemase-producing K. pneumoniae clinical isolates (n = 29) at different time intervals. All experiments in a–b was performed as three biologically independent experiments, and the mean ± s.d. is shown. p values were determined using an unpaired, two-tailed Student’s t test.